81 FR 19186 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 64 (April 4, 2016)

Page Range		19186-19186
FR Document		2016-07626

Federal Register, Volume 81 Issue 64 (Monday, April 4, 2016)

[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Page 19186]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-07626]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA), 
RFA-CE-16-003, Research on Prescription Opioid Use, Opioid Prescribing, 
and Associated Heroin Risk.
    Time and Date: 8:30 a.m.-5:00 p.m., EDT, April 27-28, 2016 
(Closed).
    Place: Atlanta Marriott Century Center, 2000 Century Blvd. NE., 
Atlanta, Georgia 30345.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Research on Prescription Opioid Use, Opioid Prescribing, and 
Associated Heroin Risk'', FOA RFA-CE-16-003.
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-80, 
Atlanta, Georgia 30341, Telephone: (770) 488-3585, EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-07626 Filed 4-1-16; 8:45 am]
BILLING CODE 4163-18-P

19186 Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices

DEPARTMENT OF HEALTH AND The Director, Management Analysis management activities, for both the
HUMAN SERVICES and Services Office, has been delegated Centers for Disease Control and
the authority to sign Federal Register Prevention and the Agency for Toxic
Centers for Disease Control and notices pertaining to announcements of Substances and Disease Registry.
Prevention meetings and other committee
Catherine Ramadei,
management activities, for both the
Advisory Committee to the Director Acting Director, Management Analysis and
Centers for Disease Control and
(ACD), Centers for Disease Control and Services Office, Centers for Disease Control
Prevention and the Agency for Toxic and Prevention.
Prevention—Health Disparities Substances and Disease Registry.
Subcommittee (HDS) [FR Doc. 2016–07626 Filed 4–1–16; 8:45 am]
Elaine L. Baker, BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of Director, Management Analysis and Services
the Federal Advisory Committee Act Office, Centers for Disease Control and
(Pub. L. 92–463), the Centers for Disease Prevention. DEPARTMENT OF HEALTH AND
Control and Prevention (CDC) [FR Doc. 2016–07527 Filed 4–1–16; 8:45 am] HUMAN SERVICES
announces the following meeting of the BILLING CODE 4163–18–P
aforementioned subcommittee: Centers for Disease Control and
Time and Date: 8:30 a.m.–4:30 p.m., Prevention
EDT, April 28, 2016. DEPARTMENT OF HEALTH AND
Place: CDC, Building 19, Rooms 256/ HUMAN SERVICES Subcommittee for Dose
257, 1600 Clifton Road NE., Atlanta, Reconstruction Reviews (SDRR),
Georgia 30329. Centers for Disease Control and Advisory Board on Radiation and
Status: Open to the public, limited Prevention Worker Health (ABRWH or the
only by the space available. The meeting Advisory Board), National Institute for
room accommodates approximately 50 Disease, Disability, and Injury Occupational Safety and Health
people. The public is welcome to Prevention and Control Special (NIOSH)
participate during the public comment Emphasis Panel (SEP): Initial Review
In accordance with section 10(a)(2) of
period, which is tentatively scheduled In accordance with Section 10(a)(2) of the Federal Advisory Committee Act
from 4:00 p.m. to 4:15 p.m. This the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease
meeting is also available by (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC),
teleconference. Please dial (866) 763– Control and Prevention (CDC) announces the following meeting for the
0273 and enter code 6158968. announces a meeting for the initial aforementioned subcommittee:
Purpose: The Subcommittee will review of applications in response to Time and Date: 10:30 a.m.–5:00 p.m.,
contribute to the ACD’s advice to the Funding Opportunity Announcement EDT, April 28, 2016.
CDC Director on strategic and other (FOA), RFA–CE–16–003, Research on Place: Audio Conference Call via FTS
health disparities and health equity Prescription Opioid Use, Opioid Conferencing.
issues and provide guidance on Prescribing, and Associated Heroin Status: Open to the public, but
opportunities for CDC. Risk. without a public comment period. The
Matters for Discussion: The Health Time and Date: 8:30 a.m.–5:00 p.m., public is welcome to submit written
Disparities Subcommittee members will EDT, April 27–28, 2016 (Closed). comments in advance of the meeting, to
discuss progress toward the Place: Atlanta Marriott Century the contact person below. Written
Subcommittee’s input to the ACD on Center, 2000 Century Blvd. NE., Atlanta, comments received in advance of the
disparity issues related to Georgia 30345. meeting will be included in the official
environmental health. Status: The meeting will be closed to record of the meeting. The public is also
The agenda is subject to change as the public in accordance with welcome to listen to the meeting by
priorities dictate. provisions set forth in Section joining the teleconference at the USA
Web links: 552b(c)(4) and (6), Title 5 U.S.C., and toll-free, dial-in number at 1–866–659–
Windows Media: http:// the Determination of the Director, 0537 and the pass code is 9933701.
wm.onlinevideoservice.com/CDC1. Management Analysis and Services Background: The Advisory Board was
Flash: http:// Office, CDC, pursuant to Public Law 92– established under the Energy Employees
www.onlinevideoservice.com/clients/ 463. Occupational Illness Compensation
CDC/?mount=CDC3. Matters for Discussion: The meeting Program Act of 2000 to advise the
Smart Phones and Mobile devices: will include the initial review, President on a variety of policy and
http:// discussion, and evaluation of technical functions required to
wowza01.sea.onlinevideoservice.com/ applications received in response to implement and effectively manage the
live/CDC3/playlist.m3u8. ‘‘Research on Prescription Opioid Use, new compensation program. Key
If you are unable to connect using the Opioid Prescribing, and Associated functions of the Advisory Board include
link, copy and paste the link into your Heroin Risk’’, FOA RFA–CE–16–003. providing advice on the development of
web browser. Contact Person for More Information: probability of causation guidelines that
Number for Technical Support: 404– M. Chris Langub, Ph.D., Scientific have been promulgated by the
639–3737. Review Officer, CDC, 4770 Buford Department of Health and Human
mstockstill on DSK4VPTVN1PROD with NOTICES

Contact Person for More Information: Highway NE., Mailstop F–80, Atlanta, Services (HHS) as a final rule; advice on
Leandris Liburd, Ph.D., M.P.H., M.A., Georgia 30341, Telephone: (770) 488– methods of dose reconstruction, which
Designated Federal Officer, Health 3585, EEO6@cdc.gov. have also been promulgated by HHS as
Disparities Subcommittee, Advisory The Director, Management Analysis a final rule; advice on the scientific
Committee to the Director, CDC, 1600 and Services Office, has been delegated validity and quality of dose estimation
Clifton Road, NE., M/S K–77, Atlanta, the authority to sign Federal Register and reconstruction efforts being
Georgia 30329 Telephone (770) 488– notices pertaining to announcements of performed for purposes of the
8343, Email: LEL1@cdc.gov. meetings and other committee compensation program; and advice on

VerDate Sep<11>2014 19:03 Apr 01, 2016 Jkt 238001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\04APN1.SGM 04APN1

Document Created: 2016-04-02 03:53:06
Document Modified: 2016-04-02 03:53:06

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		8:30 a.m.-5:00 p.m., EDT, April 27-28, 2016 (Closed).
FR Citation		81 FR 19186

81 FR 19186 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 81, Issue 64 (April 4, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention